Stocks
Allogene Therapeutics (ALLO) Net profit US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Net profit, bln rub | ? | -184.6 | -233.5 | -244.8 | -329.8 | -327.3 | -283.4 | ||
| Changes by years, y/y, % | -13% | +26% | +5% | +35% | -1% | +9.1% | |||
Allogene Therapeutics. Net profit US GAAP, bln rub
Allogene Therapeutics. Net profit US GAAP, changes, %
Allogene Therapeutics. Net profit US GAAP, sum by quarters, bln rub
Allogene Therapeutics (ALLO) Net profit US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Net profit, bln rub | ? | -61.3 | -85.8 | -65.0 | -66.4 | -66.3 | -283.4 | |
| Changes by years, y/y, % | -25% | -8% | -34% | -15% | +8% | |||
| Changes by quarters, q/q, % | -21% | +40% | -24% | +2% | 0% | |||
